Search Results - "Hamshaw, Isabel"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    IS4‐FAM, a fluorescent tool to study CXCR4 affinity and competitive antagonism in native cancer cells.

    Authors: Hamshaw, Isabel Cominetti, Marco M. D. Nana‐Akyin, Princess et al.

    Source: Pharmacology Research & Perspectives. Oct2024, Vol. 12 Issue 5, p1-7. 7p.

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    The role of PKC and PKD in CXCL12 and CXCL13 directed malignant melanoma and acute monocytic leukemic cancer cell migration.

    Authors: Hamshaw, Isabel Ellahouny, Youssef Malusickis, Artur et al.

    Source: Cellular Signalling. Jan2024, Vol. 113, pN.PAG-N.PAG. 1p.

    Save to List
  3. 3

    The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis.

    Authors: Hamshaw, Isabel Cominetti, Marco M.D. Lai, Wing-Yee et al.

    Source: Biochemical Pharmacology. Dec2023, Vol. 218, pN.PAG-N.PAG. 1p.

    Save to List
  4. 4

    Investigations into novel antagonists of the CXCR4 chemokine receptor to prevent the migration of cancerous cells

    Authors: Hamshaw, Isabel

    URL: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.828879

    Save to List
  5. 5

    PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists.

    Authors: Hamshaw I Straube A Stark R et al.

    Source: Frontiers in pharmacology [Front Pharmacol] 2023 Dec 14; Vol. 14, pp. 1285779. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).

    Publication Type: Journal Article

    Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

    PDF Full Text
    Save to List

Search Tools: